 |
 Video: What is a Stock Split?
|
|
|
| Recro Pharma is a contract development and manufacturing organization, solving formulation and manufacturing challenges primarily in small molecule therapeutic development. Co. utilizes its formulation and development knowledge to develop and manufacture pharmaceutical products using proprietary delivery technologies and know-how for partners who develop and commercialize or plan to commercialize these products. Co. has launched its clinical trials support services capabilities, which includes preparation of clinical trial supplies, as well as services dedicated to the development and Good Manufacturing Practices, of high-potency products. According to our REPH split history records, REPH has had 1 split. | |
|
REPH (REPH) has 1 split in our REPH split history database. The split for REPH took place on November 22, 2019. This was a 1115 for 1000 split, meaning for each 1000 shares of REPH owned pre-split, the shareholder now owned 1115 shares. For example, a 1000 share position pre-split, became a 1115 share position following the split.
When a company such as REPH splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the REPH split history from start to finish, an original position size of 1000 shares would have turned into 1115 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into REPH shares, starting with a $10,000 purchase of REPH, presented on a split-history-adjusted basis factoring in the complete REPH split history.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
04/24/2014 |
|
| End date: |
03/21/2022 |
|
| Start price/share: |
$6.00 |
|
| End price/share: |
$2.09 |
|
| Starting shares: |
1,666.67 |
|
| Ending shares: |
1,974.49 |
|
| Dividends reinvested/share: |
$2.80 |
|
| Total return: |
-58.73% |
|
| Average Annual Total Return: |
-10.58% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$4,127.96 |
|
| Years: |
7.91 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/24/2014 |
|
| End date: |
03/21/2022 |
|
| Start price/share: |
$6.00 |
|
| End price/share: |
$2.09 |
|
| Dividends collected/share: |
$2.80 |
|
| Total return: |
-18.50% |
|
| Average Annual Total Return: |
-2.55% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$8,151.51 |
|
| Years: |
7.91 |
|
|
|
| Date |
Ratio |
| 11/22/2019 | 1115 for 1000 |
|
|
Free REPH Email Alerts:
